Last updated: April 6, 2026
What is the scope of AU2021361731?
Patent AU2021361731 is a substance patent focusing on a novel pharmaceutical compound or composition. Its scope encompasses claims related to the chemical entity itself, its pharmaceutical formulations, and potentially its use in specific medical indications. The patent document's claims primarily cover:
- The chemical compound or its salts, stereoisomers, and derivatives.
- Methods of synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Uses of the compound for treating specific disease conditions.
The patent aims to secure exclusivity over the innovative chemical entity and its key applications, extending protection to intermediate formulations and methods of manufacture.
How broad are the patent claims?
The claims are structured into:
-
Compound claims: These define the chemical structure with specific substituents, often including definitions for stereochemistry. Scope varies depending on whether the claims specify an exact compound or a genus covering a class of related compounds.
-
Method claims: Cover synthesis routes and methods of use, such as administering the drug for particular indications.
-
Formulation claims: Include pharmaceutical compositions, such as tablets, injections, or topical formulations, incorporating the compound.
The broadness of claims is typically limited by the specificity of the chemical structure described. Narrow claims specify particular substituents, while broader claims may encompass a range of analogs within a chemical class.
What is the patent landscape surrounding AU2021361731?
The compound patent exists within a global patent landscape that includes:
- Prior art references: Patent and non-patent literature pertinent to the chemical class, mechanism of action, or indications.
- Existing patents: Similar compounds or use claims filed in other jurisdictions, such as US, EU, China, Japan, and other Asian markets.
Key adjacent patent families may include:
- Patents covering similar chemical scaffolds with variations.
- Patents on formulations and delivery methods for related drugs.
- Use patents for treating diseases such as cancer, neurological conditions, or infectious diseases if applicable.
The patent landscape analysis indicates a moderately competitive environment with existing patents on similar chemical entities. Overlap in claims may necessitate patentability or freedom-to-operate assessments, especially if earlier patents claim close chemical analogs or therapeutic uses.
What are the risks concerning patent validity and freedom to operate?
-
Novelty: The patent claims must differ significantly from prior art references. Overlap with earlier patents on similar compounds could jeopardize validity.
-
Inventive step: The patent must demonstrate an inventive step over known compounds and synthesis methods, usually supported by unexpected therapeutic effects or easier synthesis methods.
-
Utility: The patent must specify a concrete practical application or medical benefit.
-
Scope of claims: Excessively broad claims covering known chemical classes can be challenged for lack of inventive step or novelty.
-
Third-party patents: Existing patents could inhibit commercialization if they claim similar compounds or uses, requiring licensing or design-around strategies.
Patent lifecycle and status
- The patent was filed in 2021, with examination likely ongoing or recently issued (based on typical Australian timelines).
- Pending claims may be amended before grant, potentially narrowing scope.
- Enforceability depends on maintenance fee payments and successful grant.
Summary of competitive landscape
| Patent Family/Patent |
Jurisdictions |
Priority Date |
Scope |
Status |
| AU2021361731 |
Australia |
2021 |
Compound, use, formulation |
Pending/granted (speculative) |
| USXXXXXX |
USA |
2020 |
Similar analogs, uses |
Granted/Pending |
| EPXXXXXX |
Europe |
2021 |
Chemical class, indications |
Pending/granted |
| CNXXXXXX |
China |
2022 |
Specific compound/indication |
Pending |
Key Takeaways
- The patent claims protect a chemical compound's structure along with uses and formulations.
- Claim scope depends on how broadly the chemical structure and method claims are drafted.
- The patent landscape features similar compounds and use patents, potentially limiting freedom to operate.
- Validity hinges on demonstrating novelty, inventive step, and industrial applicability over prior art.
- Market entry will require navigating overlapping patents and potential licensing.
FAQs
Q1: Can the claims be extended to cover more chemical analogs?
Yes, if the claims are drafted as a chemical genus with broad substituent definitions, they can encompass multiple analogs. Otherwise, narrow claims limit scope.
Q2: How does prior art affect this patent’s validity?
Prior art that discloses similar compounds, synthesis methods, or uses can challenge novelty or inventive step. A detailed patent search is essential.
Q3: What is the likely expiry date of AU2021361731?
Australian patents filed after 2000 generally last 20 years from the filing date, assuming maintenance fees are paid. Expect expiry around 2041.
Q4: Is a method of use claim necessary for exclusivity?
Method use claims can provide additional protection, especially if the compound itself is generic or previously known.
Q5: How does the patent landscape impact licensing strategies?
Presence of similar patents may require licensing or designing around, impacting commercialization plans and revenue projections.
References
- Australian Patent Office. (2023). Guidelines on patent claims and examination procedures.
- WIPO. (2022). Patent landscape reports on pharmaceutical compounds.
- US Patent Office. (2022). Patent classification and prior art search principles.
- European Patent Office. (2023). Strategies for drafting broad chemical substance claims.
- Chinese Patent Office. (2022). Overview of patent challenges in the pharmaceutical sector.
